XTX Topco Ltd Invests $258,000 in Bruker Co. (NASDAQ:BRKR)

XTX Topco Ltd acquired a new position in Bruker Co. (NASDAQ:BRKR) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor acquired 4,047 shares of the medical research company’s stock, valued at approximately $258,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Rise Advisors LLC acquired a new stake in shares of Bruker in the first quarter worth $27,000. Covestor Ltd grew its stake in shares of Bruker by 139.1% in the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock worth $34,000 after acquiring an additional 210 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of Bruker by 120.4% in the second quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock worth $25,000 after acquiring an additional 218 shares during the last quarter. Neo Ivy Capital Management acquired a new stake in shares of Bruker in the fourth quarter worth $30,000. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Bruker by 40.7% in the first quarter. EverSource Wealth Advisors LLC now owns 858 shares of the medical research company’s stock worth $81,000 after acquiring an additional 248 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on BRKR. Jefferies Financial Group began coverage on Bruker in a research report on Monday, June 3rd. They issued a “buy” rating and a $85.00 target price for the company. TD Cowen reduced their target price on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. The Goldman Sachs Group reduced their target price on Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a research report on Tuesday, July 9th. Citigroup reduced their target price on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, July 10th. Finally, Wells Fargo & Company began coverage on Bruker in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 target price for the company. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $81.40.

Bruker Stock Performance

Shares of NASDAQ:BRKR opened at $70.67 on Friday. Bruker Co. has a twelve month low of $53.79 and a twelve month high of $94.86. The firm has a market cap of $10.27 billion, a PE ratio of 25.70, a price-to-earnings-growth ratio of 2.43 and a beta of 1.18. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.75 and a current ratio of 1.65. The business has a fifty day moving average of $65.08 and a 200-day moving average of $71.96.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.52. The company had revenue of $800.70 million during the quarter, compared to analyst estimates of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The firm’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same period last year, the company posted $0.50 earnings per share. On average, equities research analysts predict that Bruker Co. will post 2.61 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were given a $0.05 dividend. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a yield of 0.28%. Bruker’s payout ratio is 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.